We are international
Donate
publications TEXT SIZE   
meeting highlights    back

A Phase I Study of HCD122 (formerly CHIR-12.12), a Monoclonal Antibody to CD40, in Relapsed/Refractory Myeloma
By William Bensinger, MD
12.18.06

Be the first to comment

 related articles